A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein

Samankaltaisia teoksia

• A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein
  Tekijä: Chen, Yingzhu, et al.
  Julkaistu: (2017)
• Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein
  Tekijä: Zhou, Haixia, et al.
  Julkaistu: (2019)
• The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection
  Tekijä: Jiaming, Lan, et al.
  Julkaistu: (2017)
• The Amino Acids 736–761 of the MERS-CoV Spike Protein Induce Neutralizing Antibodies: Implications for the Development of Vaccines and Antiviral Agents
  Tekijä: Yang, Yang, et al.
  Julkaistu: (2014)
• Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus
  Tekijä: Lan, Jiaming, et al.
  Julkaistu: (2018)